No End In Sight: FDA Postpones Another In-Person Meeting Due To COVID-19
Executive Summary
The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.
You may also be interested in...
Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.
Sign Of Normalcy? US FDA Schedules Meeting But Pauses Non-COVID Guidance Development
As the agency and country plot the steps to reopening, a full resumption of activities still seems a long way off.
Back To Normal? US FDA Schedules In-Person Meeting But Pauses Non-COVID Guidance Development
As the agency and country plot the steps to reopening, a full resumption of activities still seems a long way off.